XML 16 R5.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Preferred Stock [Member]
Common Stock
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Total Precipio, Inc.
Noncontrolling Interest [Member]
Total
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2018   $ 23 $ 53,796 $ (47,696) $ 6,123   $ 6,123
Balance at beginning of period (in shares) at Dec. 31, 2018 47 2,298,738          
Increase (Decrease) in Stockholders' Equity              
Net (loss) income       (9,462) (9,462)   (9,462)
Conversion of convertible notes into common stock   $ 24 7,366   7,390   7,390
Conversion of convertible notes into common stock (in shares)   2,439,173          
Issuance of common stock in connection with purchase agreements   $ 21 5,150   5,171   5,171
Issuance of common stock in connection with purchase agreements (in shares)   2,088,077          
Issuance of common stock upon exercise of warrants   $ 3 1,572   1,575   1,575
Issuance of common stock upon exercise of warrants (in shares)   310,200          
Write-off warrant liability in conjunction with warrant exercises     2,364   2,364   2,364
Beneficial conversion feature on issuance of notes     1,792   1,792   1,792
Write-off debt discounts (net of debt premiums) in conjunction with convertible note conversions     (590)   (590)   (590)
Write-off debt derivative liability in conjunction with convertible note conversions     477   477   477
Sock-based compensation     455   455   455
Payment of fractional common shares in conjunction with reverse stock split     (1)   (1)   (1)
Payment of fractional common shares in conjunction with reverse stock split (in shares)   (71)          
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Sep. 30, 2019   $ 71 72,381 (57,158) 15,294   15,294
Balance at end of period (in shares) at Sep. 30, 2019 47 7,136,117          
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2018   $ 23 53,796 (47,696) 6,123   6,123
Balance at beginning of period (in shares) at Dec. 31, 2018 47 2,298,738          
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Dec. 31, 2019   $ 79 74,065 (60,939) 13,205   13,205
Balance at end of period (in shares) at Dec. 31, 2019 47 7,898,117          
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Jun. 30, 2019   $ 60 69,428 (55,261) 14,227   14,227
Balance at beginning of period (in shares) at Jun. 30, 2019 47 5,993,369          
Increase (Decrease) in Stockholders' Equity              
Net (loss) income       (1,897) (1,897)   $ (1,897)
Conversion of preferred stock into common stock (in shares)             0
Conversion of convertible notes into common stock     118   118   $ 118
Conversion of convertible notes into common stock (in shares)   52,748          
Issuance of common stock in connection with purchase agreements   $ 11 2,750   2,761   2,761
Issuance of common stock in connection with purchase agreements (in shares)   1,090,000          
Write-off debt discounts (net of debt premiums) in conjunction with convertible note conversions     (63)   (63)   (63)
Sock-based compensation     148   148   148
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Sep. 30, 2019   $ 71 72,381 (57,158) 15,294   15,294
Balance at end of period (in shares) at Sep. 30, 2019 47 7,136,117          
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Dec. 31, 2019   $ 79 74,065 (60,939) 13,205   13,205
Balance at beginning of period (in shares) at Dec. 31, 2019 47 7,898,117          
Increase (Decrease) in Stockholders' Equity              
Net (loss) income       (8,756) (8,756) $ 27 (8,729)
Conversion of convertible notes into common stock   $ 39 2,137   2,176   2,176
Conversion of convertible notes into common stock (in shares)   3,908,145          
Issuance of common stock in connection with purchase agreements   $ 49 6,872   6,921   6,921
Issuance of common stock in connection with purchase agreements (in shares)   4,870,654          
Write-off beneficial conversion feature in conjunction with convertible note extinguishment     (523)   (523)   (523)
Write-off debt discounts (net of debt premiums) in conjunction with convertible note conversions     270   270   270
Sock-based compensation     541   541   541
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Sep. 30, 2020   $ 167 83,362 (69,695) 13,834 27 13,861
Balance at end of period (in shares) at Sep. 30, 2020 47 16,676,916          
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Beginning Balance at Jun. 30, 2020   $ 146 78,857 (66,393) 12,610 17 12,627
Balance at beginning of period (in shares) at Jun. 30, 2020 47 14,616,916          
Increase (Decrease) in Stockholders' Equity              
Net (loss) income       (3,302) (3,302) 10 (3,292)
Issuance of common stock in connection with purchase agreements   $ 21 4,293   4,314   4,314
Issuance of common stock in connection with purchase agreements (in shares)   2,060,000          
Sock-based compensation     212   212   212
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance at Sep. 30, 2020   $ 167 $ 83,362 $ (69,695) $ 13,834 $ 27 $ 13,861
Balance at end of period (in shares) at Sep. 30, 2020 47 16,676,916